The U.S. Food and Drug Administration (FDA) issued a draft guidance titled Data Standards for Drug and Biological Product Submissions Containing Real-World Data on October 21, 2021. The guidance ...
Industry leaders want to see more flexibility and clarity from the US Food and Drug Administration (FDA) as it seeks to finalize guidance on the use real-world data (RWD) from electronic health ...
Interviews conducted with biopharma executives in a Tufts CSDD study reveals growing RWD adoption and ROI across all phases of drug development SAN FRANCISCO, April 7, 2026 /PRNewswire/ -- New ...